Abstract
Experimental and clinical findings strongly support the concept that thyroid hormone (TH) plays a fundamental role in the cardiovascular (CV) homeostasis. CV diseases represent a major public health care and economic problem being one of the principal causes of morbility, mortality and hospitalization. In particular, chronic heart failure (HF) is one of the most common reasons for general practitioners consultations in people >65–70 years old. TH derangement may have a key role in the evolution process of HF. In HF, the main and earlier alteration of the thyroid function is referred to as “low-T3” syndrome characterized by the reduction in serum total T3 and free T3 with normal levels of thyroxine (T4) and thyrotropin (TSH). This syndrome may affect till one-third of advanced HF patients. The main goal of this mini-review is to examine the main pathophysiological and clinical links between an altered thyroid metabolism and CV diseases, namely HF during progression of disease from organ specific to systemic disorder.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Klein I, Ojamaa K (2001) Mechanisms of disease: thyroid hormone and the cardiovascular system. New Engl J Med 344:501–509
Gerdes AM, Iervasi G (2010) Thyroid replacement therapy and heart failure. Circulation 122:385–393. doi:10.1161/CIRCULATIONAHA.109.917922
Colantuoni A, Marchiafava PL, Lapi D, Forini FS, Iervasi G (2005) Effects of tetraiodothyronine and triiodothyronine on hamster cheek pouch microcirculation. Am J Physiol Heart Circ Physiol 288:H1931–H1936. doi:10.1152/ajpheart.00931.2004
Galli E, Pingitore A, Iervasi G (2010) Thyroid hormone in the pathophysiology of heart failure: clinical evidence. Heart Fail Rev 15:155–169. doi:10.1007/s10741-008-9126-6
Mizuma H, Murakami M, Mori M (2001) Thyroid hormone activation in human vascular smooth muscle cells—expression of type II iodothyronine deiodinase. Circulation Research 88:313–318. doi:10.1161/01.RES.88.3.313
Mourouzis I, Forini F, Pantos C, Iervasi G (2011) Thyroid hormone and cardiac disease: from basic concepts to clinical application. J Thyroid Res 958626. doi:10.4061/2011/958626
Pingitore A, Landi P, Taddei MC, Ripoli A, L’Abbate A, Iervasi G (2005) Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med 118:132–136. doi:10.1016/j.amjmed.2004.07.052
Iervasi G, Molinaro S, Landi P, Taddei MC, Galli E, Mariani F, L’Abbate A, Pingitore A (2007) Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med 167:1526–1532. doi:10.1001/archinte.167.14.1526
Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J (2010) Thyroid Studies Collaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304(12):1365–1374. doi:10.1001/jama.2010.1361
Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Åsvold BO, Sgarbi JA, Völzke H, Gencer B, Maciel RM, Molinaro S, Bremner A, Luben RN, Maisonneuve P, Cornuz J, Newman AB, Khaw KT, Westendorp RG, Franklyn JA, Vittinghoff E, Walsh JP, Rodondi N (2012) Thyroid Studies Collaboration. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Int Med 172:799–809. doi:10.1001/archinternmed.2012.402
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iervasi, G., Nicolini, G. Thyroid hormone and cardiovascular system: from basic concepts to clinical application. Intern Emerg Med 8 (Suppl 1), 71–74 (2013). https://doi.org/10.1007/s11739-013-0911-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-013-0911-4